Stay updated on Selinexor & Lenalidomide in Myeloma Post-transplant Clinical Trial

Sign up to get notified when there's something new on the Selinexor & Lenalidomide in Myeloma Post-transplant Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Selinexor & Lenalidomide in Myeloma Post-transplant Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    Change Detected
    Summary
    Added Revision: v3.3.3 to the Record History; removed the HHS Vulnerability Disclosure link and Revision: v3.3.2.
    Difference
    0.2%
    Check dated 2025-12-24T11:24:18.000Z thumbnail image
  3. Check
    21 days ago
    No Change Detected
  4. Check
    28 days ago
    No Change Detected
  5. Check
    43 days ago
    Change Detected
    Summary
    The Record History page now includes an added revision entry for Revision: v3.3.2 and the entry Revision: v3.2.0 is removed.
    Difference
    0.1%
    Check dated 2025-11-25T12:00:57.000Z thumbnail image
  6. Check
    50 days ago
    Change Detected
    Summary
    The government funding and operating status notice on the Record History page was removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.8%
    Check dated 2025-11-18T07:20:36.000Z thumbnail image
  7. Check
    71 days ago
    Change Detected
    Summary
    The history shows updates to the Study Status and Recruitment Status across revisions. Later versions add details on Study Design and Contacts/Locations.
    Difference
    0.1%
    Check dated 2025-10-27T20:57:44.000Z thumbnail image
  8. Check
    93 days ago
    Change Detected
    Summary
    Updated operating-status notice and version 3.2.0; removed version 3.1.0.
    Difference
    13%
    Check dated 2025-10-06T07:58:44.000Z thumbnail image
  9. Check
    100 days ago
    Change Detected
    Summary
    Changed the revision from v3.0.2 to v3.1.0, indicating a minor version update with no other content changes.
    Difference
    0.3%
    Check dated 2025-09-29T04:39:21.000Z thumbnail image

Stay in the know with updates to Selinexor & Lenalidomide in Myeloma Post-transplant Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Selinexor & Lenalidomide in Myeloma Post-transplant Clinical Trial page.